Osim Founder Ron Sim Withdraws Legal Claims Against Trek 2000 Following New Investors Entry SLND Q1 2026 Earnings EPS Misses Estimates as Losses Widen Stock Declines 47 Innovent Biologics Surges 10 on 105 Billion Oncology Deal with Pfizer